Tuesday, 16 October 2018

Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU

Rival versions of the world’s top-selling drug, AbbVie's Humira, went on sale in Europe on Tuesday, years ahead of similar cut-price copies being available in the United States.


No comments:

Post a Comment